Drug
Relacorilant Fasted
Relacorilant Fasted: highest development phase Phase 1, developed by Corcept Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Corcept Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Relacorilant Fasted NCT03442621 | Phase 1 | Healthy |
Latest
No recent events.
Follow Relacorilant Fasted on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.